(4S, 5R) -3-tert-butoxycarbony-2- (4-anisyl) -4-phenyl-5-oxazolidinecarboxylic Acid CAS 155396-69-3 / CAS 196404-55-4

Khoom Piav Qhia

Khoom npe: (4S, 5R) -3-tert-butoxycarbony-2- (4-anisyl) -4-phenyl-5-oxazolidinecarboxylic acid CAS 155396-69-3 / CAS 196404-55-4

Txhais:

(2R, 4S, 5R) -3-t-butoxycarbonyl-2- (4-methoxyphenyl) -4-phenyl-1,3-oxazolidine-5-carboxylic acid;

(2R, 4S, 5R) - (2R, 4S, 5R) -3-tert-butoxycarbonyl-2- (4-methoxyphenyl) -4-phenyl-1,3-oxazolidine-5-carboxylic acid;

(2R, 4S, 5R) -3- (tert-Butoxycarbonyl) -2- (4-methoxyphenyl) -4-phenyloxazolidine-5-carboxylic acid;

(4S, 5R) -3-tert-butoxycarbony-2- (4-anisy) -4-phenyl-5-oxazolidinecarboxylic acid;

(4S, 5R) -N- (t-butyloxycarbonyl) -2- (4-methoxyphenyl) -4-phenyl-5-oxazolidinecarboxylic acid;

(4S, 5R) -2- (4-Methoxyphenyl) -3 - {[(2-methyl-2-propanyl) oxi] carbonyl} -4-phenyl-1,3-oxazolidine-5-carboxylic acid;

Tshuaj & Lub Cev Lub Cev

Zog: Cov hmoov dawb crystalline

Assay: ≥99.0%,

Qhov ceev: 1.238g / cm3

Lub Ntsiab Kub: 573.799 ℃ ntawm 760 mmHg

Flash Point: 300.823 ℃

Performance index: 1.568

Vapor Siab: 0mmHg ntawm 25 ℃

soluble hauv methanol, ethanol, DMSO thiab lwm cov organic solvents.

Cov ntawv thov: (4S, 5R) -3-tert-Butoxycarbony-2- (4-anisyl) -4-phenyl-5-oxazolidine carboxylic acid yog qhov nruab nrab / tsis huv rau docetaxel hydrate. Nws kuj tseem siv tau los ua ke quinoline-docetaxel analogues uas muaj cov haujlwm ua anticancer.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam hauv qab patent yog muab rau R & D hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.

Cim npe nrov: (4s, 5r) -3-tert-butoxycarbony-2- (4-anisyl) -4-phenyl-5-oxazolidinecarboxylic acid cas 155396-69-3 / cas 196404-55-4, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag

• Tug: 10-DAB CAS 32981-86-5
• Tom ntej: Isopropyl Cawv CAS 67-63-0